Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial

Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The website has been updated to version 2.11.2 on October 1, 2024, following the removal of version 2.11.0 on September 19, 2024.
    Difference
    1.0%
    Check dated 2024-10-03T04:48:58.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated to version 2.11.0, while a notice regarding delays in displaying study record information has been removed.
    Difference
    4%
    Check dated 2024-09-25T22:22:41.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    4%
    Check dated 2024-09-18T16:30:49.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    New content was added on September 5, 2024, following the deletion of previous content on August 30, 2024.
    Difference
    0.6%
    Check dated 2024-09-11T07:26:29.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.3 on August 30, 2024, following the removal of version 2.10.2 on August 27, 2024.
    Difference
    0.6%
    Check dated 2024-09-04T04:30:05.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    New content was added on August 27, 2024, following the deletions that occurred on August 13, 2024.
    Difference
    0.3%
    Check dated 2024-08-28T02:15:58.000Z thumbnail image

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.